ACTU vs SPG · $49.0M cap vs rev $3.55B
Actuate Therapeutics, Inc. Common stock (ACTU) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
SPG (SPG) common stock.
ACTU does not have a complete income-statement cache yet.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
ACTU currently screens at market cap $49.0M. SPG currently screens at market cap $0.
Not investment advice. Open the ACTU and SPG stock pages for the full models.
Not investment advice.